These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 3014550)

  • 21. Enzyme visualization with partially dehydrated agarose substrate layers: detection of paraoxonase after thin-layer isoelectric focusing in agarose.
    Haas A; Geldmacher-von Mallinckrodt M
    Electrophoresis; 1990 Aug; 11(8):621-6. PubMed ID: 1963139
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polymorphism of human serum paraoxonase.
    Geldmacher-von Mallinckrodt M
    Hum Genet Suppl; 1978; (1):65-8. PubMed ID: 218905
    [No Abstract]   [Full Text] [Related]  

  • 23. Paraoxonase 1 (PON1) organophosphate hydrolysis is not reduced in ALS.
    Wills AM; Landers JE; Zhang H; Richter RJ; Caraganis AJ; Cudkowicz ME; Furlong CE; Brown RH
    Neurology; 2008 Mar; 70(12):929-34. PubMed ID: 18347314
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum arylesterase (paraoxonase) activity following myocardial infarction.
    Secchiero S; Mussap M; Zaninotto M; Bertorelle R; Burlina A
    Clin Chim Acta; 1989 Jul; 183(1):71-5. PubMed ID: 2548773
    [No Abstract]   [Full Text] [Related]  

  • 25. Number of loci responsible for the inheritance of high and low activity of paraoxonase.
    Nielsen A; Eiberg H; Mohr J
    Clin Genet; 1986 Mar; 29(3):216-21. PubMed ID: 3009059
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ecogenetic studies in Atacameño Indians.
    Goedde HW; Rothhammer F; Benkmann HG; Bogdanski P
    Hum Genet; 1984; 67(3):343-6. PubMed ID: 6088389
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum paraoxonase and arylesterase activities in patients with lacunar infarction: a case control study.
    Moghtaderi A; Hashemi M; Dabiri S; Moazeni-Roodi A; Hosseini M
    Clin Biochem; 2011 Mar; 44(4):288-92. PubMed ID: 21167145
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma paraoxonase polymorphism: a new enzyme assay, population, family, biochemical, and linkage studies.
    Mueller RF; Hornung S; Furlong CE; Anderson J; Giblett ER; Motulsky AG
    Am J Hum Genet; 1983 May; 35(3):393-408. PubMed ID: 6305189
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Number of "high genes" involved in determining the activity of paraoxonase.
    Nielsen A; Eiberg H; Fenger K; Mohr J
    Clin Genet; 1986 Jul; 30(1):41-9. PubMed ID: 3019596
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetics of paraoxonase.
    Eiberg H; Mohr J
    Ann Hum Genet; 1981 Oct; 45(4):323-30. PubMed ID: 6282178
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Purification of human serum paraoxonase/arylesterase. Evidence for one esterase catalyzing both activities.
    Gan KN; Smolen A; Eckerson HW; La Du BN
    Drug Metab Dispos; 1991; 19(1):100-6. PubMed ID: 1673382
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Linkage relationships of paraoxonase (PON) with other markers: indication of PON-cystic fibrosis synteny.
    Eiberg H; Mohr J; Schmiegelow K; Nielsen LS; Williamson R
    Clin Genet; 1985 Oct; 28(4):265-71. PubMed ID: 2998653
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Population, formal genetics, and linkage relations of the phosphoglycolate phosphatase (PGP)--E.C.3.1.3.18.
    Brink W; Baur MP; Rittner C
    Hum Genet; 1981; 59(4):386-8. PubMed ID: 6277765
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stability of the paraoxonase phenotyping ratio in collections of human sera with differing storage times.
    Brackley M; Carro-Ciampi G; Stewart DJ; Lowden JA; Ray AK; Kalow W
    Res Commun Chem Pathol Pharmacol; 1983 Jul; 41(1):65-78. PubMed ID: 6312517
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Paraoxonase polymorphism in northwestern Indians.
    Singh S; Verma M; Nain CK; Co L; Goel RC; Sharma BK
    Int J Clin Pharmacol Ther; 1998 Oct; 36(10):545-8. PubMed ID: 9799059
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distribution of serum paraoxon hydrolyzing activity in family and population samples.
    Ishimoto G; Uchida H; Tsuge A
    Nihon Hoigaku Zasshi; 1987 Aug; 41(4):347-50. PubMed ID: 2826857
    [No Abstract]   [Full Text] [Related]  

  • 37. Characteristics of the genetically determined allozymic forms of human serum paraoxonase/arylesterase.
    Smolen A; Eckerson HW; Gan KN; Hailat N; La Du BN
    Drug Metab Dispos; 1991; 19(1):107-12. PubMed ID: 1673383
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum paraoxonase and arylesterase activities for the evaluation of patients with chronic hepatitis.
    Aslan M; Horoz M; Nazligul Y; Bolukbas C; Bolukbas FF; Selek S; Aksoy N; Erel O
    Int J Clin Pract; 2008 Jul; 62(7):1050-5. PubMed ID: 17887991
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic polymorphism of human phosphoglycolate phosphatase (PGP).
    Barker RF; Hopkinson DA
    Ann Hum Genet; 1978 Oct; 42(2):143-51. PubMed ID: 215071
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inherited and acquired interactions between ACHE and PON1 polymorphisms modulate plasma acetylcholinesterase and paraoxonase activities.
    Bryk B; BenMoyal-Segal L; Podoly E; Livnah O; Eisenkraft A; Luria S; Cohen A; Yehezkelli Y; Hourvitz A; Soreq H
    J Neurochem; 2005 Mar; 92(5):1216-27. PubMed ID: 15715671
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.